Avid Bioservices Inc (CDMO): I agree 100% Some ask how so much inf...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	85
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: hopefilled2014 post# 273307

Sunday, 09/25/2016 11:24:03 AM

Sunday, September 25, 2016 11:24:03 AM

I agree 100%

Some ask how so much information lands on this board and if you ask me....it's like some outliner melting pot of research that some don't care to hold back most information related to PS Targeting and for me....I even try to stretch it out and it makes for one hell of a big puzzle

It's fun watching many of the pieces resurface time and time again

I would never have held onto as many shares if it were not digging deeper and hopefully it helped others hold onto many shares that would have slipped away and regretted later on...

Last chance to get in at these firesale prices ...the window is closing soon

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!